Adverse Pregnancy Outcome, the Uteroplacental Interface, and Preventive Strategies

Seminars in Perinatology

Volumn 31, Issue 4, 2007, Pages 208-212

  Hossain, Nazli ^a   Paidas, Michael J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adverse pregnancy outcomes; endothelial cell dysfunction; placenta; preeclampsia

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; CALCIUM; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN;

FETUS WASTAGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MORBIDITY; MORTALITY; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOPHILIA;

ANTICOAGULANTS; ASPIRIN; FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; HEPARIN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA; THROMBOSIS; UTERUS;

EID: 34548357312     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2007.05.002     Document Type: Review

References (30)

1. Chaiworapongsa T., Romero R., Espinoza J., et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 190 (2004) 1541-1547 discussion 1547-1550
2. Maynard S.E., Venkatesha S., Thadhani R., et al. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res 57 (2005) 1R-7R
3. Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355 (2006) 992-1005
4. Yu C.K., Smith G.C., Papageorghiou A.T., et al. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 193 (2005) 429-436
5. Kupferminc M.J. Thrombophilia and preeclampsia: the evidence so far. Clin Obstet Gynecol 48 (2005) 406-415
6. Mello G., Parretti E., Marozio L., et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 46 (2005) 1270-1274
7. Infante-Rivard C., Rivard G.E., Guiguet M., et al. Thrombophilic polymorphisms and intrauterine growth restriction. Epidemiology 16 (2005) 281-287
8. Paidas M.J., Ku D.H., Langhoff-Roos J., et al. Inherited thrombophilias and adverse pregnancy outcome: screening and management. Semin Perinatol 29 (2005) 150-163
9. Roque H., Paidas M.J., Funai E.F., et al. Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 91 (2004) 290-295
10. Salafia C.M., Minior V.K., Pezzullo J.C., et al. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol 173 (1995) 1049-1057
11. Ghidini A., Salafia C.M., and Pezzullo J.C. Placental vascular lesions and likelihood of diagnosis of preeclampsia. Obstet Gynecol 90 (1997) 542-545
12. Gris J.C., Quere I., Monpeyroux F., et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent: the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost 81 (1999) 891-899
13. Papageorghiou A.T., Yu C.K., and Nicolaides K.H. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 18 (2004) 383-396
14. Nicolaides K.H., Bindra R., Turan O.M., et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 27 (2006) 13-17
15. Spencer K., Yu C.K., Cowans N.J., et al. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 25 (2005) 949-953
16. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353 (2005) 2001-2011
17. Halligan A., Bonnar J., Sheppard B., et al. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynecol 101 (1994) 488-492
18. Paidas M., Ku D.H., Triche E., et al. Does heparin therapy improve pregnancy outcome in patients with thrombophilias?. J Thromb Haemost 2 (2004) 1194-1195
19. Brenner B., Bar J., Ellis M., et al. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. Fertil Steril 84 (2005) 770-773
20. Gris J.C., Dekker G., and Cohen H. Antithrombotic prophylaxis for pregnancy loss Prothrombotic mechanisms in preeclampsia. Inherited thrombophilia and pregnancy loss-epidemiology. Thromb Res 115 suppl 1 (2005) 30-32
21. Rodger M., Gris J.-C., Quere I., et al. Important publication missing key information. Blood 104 (2004) 3413-3414
22. Polyzos N.P., Mauri D., Tsappi M., et al. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv 62 (2007) 202-206
23. Hofmeyr G.J., Atallah A.N., Duley L., et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 3 (2006) CD001059
24. Hutton B., Sharma R., Fergusson D., et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. Br J Obstet Gynaecol 114 (2007) 134-142
25. Triolo G., Ferrante A., Ciccia F., et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48 (2003) 728-731
26. Maki M., Kobayashi T., Terao T., et al. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group. Thromb Haemost 84 (2000) 583-590
27. Sergio F., Maria Clara D., Gabriella F., et al. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy 25 (2006) 115-127
28. Duhl AJ, Paidas M, Ural SH, et al: Antithrombotic therapy and pregnancy. Consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse perinatal outcomes. Am J Obstet Gynecol 2007, in press
29. Hills F.A., Abrahams V.M., Gonzalez-Timon B., et al. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 12 (2006) 237-243
30. Urban G, Vergani P, Tironi R, et al: Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in antecedent pregnancy. International Journal of Fertility & Women's Medicine, accepted for publication